(Q39365138)

11 September 2017

title

Therapeutic advantages of third generation antihistamines (English)

1 reference

11 September 2017

1 reference

Handley DA

1

1 reference

11 September 2017

Magnetti A

series ordinal

2

1 reference

11 September 2017

Higgins AJ

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 July 1998

1 reference

Expert Opinion on Investigational Drugs

11 September 2017

published in

1 reference

11 September 2017

volume

7

1 reference

11 September 2017

issue

7

1 reference

11 September 2017

page(s)

1045-1054

1 reference

Definition and antagonism of histamine H 2 -receptors

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

The pharmacology and use of H1-receptor-antagonist drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

A double-blind, placebo controlled study of the effect of the specific histamine H1-receptor antagonist, terfenadine, in chronic severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

Cardiac actions of antihistamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

Torsade de pointes with an antihistamine metabolite: potassium channel blockade with desmethylastemizole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

Effect of descarboethoxyloratadine, the major metabolite of loratadine, on the human cardiac potassium channel Kv1.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

Loratadine administered concomitantly with erythromycin: pharmacokinetic and electrocardiographic evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.7.7.1045

10.1517/13543784.7.7.1045

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference